UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 8, 2021
Accession Number: 0001213900-21-035564
Submission Type: POS AM
CIK: 0001506251
Company Name: Citius Pharmaceuticals, Inc.
File Number: 333-217956